203 related articles for article (PubMed ID: 30719453)
21. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis.
Parekh P; Rao KV
Cell Biol Int; 2007 Jan; 31(1):35-43. PubMed ID: 17055752
[TBL] [Abstract][Full Text] [Related]
22. (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.
Wang J; Zhang S; Li Z; Yang J; Huang C; Liang R; Liu Z; Zhou R
Tumour Biol; 2011 Feb; 32(1):223-31. PubMed ID: 20890798
[TBL] [Abstract][Full Text] [Related]
23. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
24. Higher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine.
Gao J; Wang Z; Wang GJ; Zhang HX; Gao N; Wang J; Wang CE; Chang Z; Fang Y; Zhang YF; Zhou J; Jin H; Qiao HL
J Pharmacol Exp Ther; 2018 May; 365(2):398-407. PubMed ID: 29467309
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging of hepatocellular carcinoma induced by diethylnitrosamine in Sprague-Dawley rats.
Li X; Zhou XP; Guan YS; Wang YX
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):427-32. PubMed ID: 16109530
[TBL] [Abstract][Full Text] [Related]
26. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
[TBL] [Abstract][Full Text] [Related]
27. Metabolic profiling of normal hepatocyte and hepatocellular carcinoma cells via
Chen Y; Chen Z; Feng JH; Chen YB; Liao NS; Su Y; Zou CY
Cell Biol Int; 2018 Apr; 42(4):425-434. PubMed ID: 29144590
[TBL] [Abstract][Full Text] [Related]
28. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
[TBL] [Abstract][Full Text] [Related]
29. In vivo 1H MR spectroscopy in the evaluation of the serial development of hepatocarcinogenesis in an experimental rat model.
Xu H; Li X; Yang ZH; Xie JX
Acad Radiol; 2006 Dec; 13(12):1532-7. PubMed ID: 17138121
[TBL] [Abstract][Full Text] [Related]
30. Diethylnitrosamine-induced liver tumorigenesis in mice.
Schulien I; Hasselblatt P
Methods Cell Biol; 2021; 163():137-152. PubMed ID: 33785162
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance spectroscopy on hepatocellular carcinoma after transcatheter arterial chemoembolization.
Bian DJ; Xiao EH; Hu DX; Chen XY; Situ WJ; Yuan SW; Sun JL; Yang LP
Chin J Cancer; 2010 Feb; 29(2):198-201. PubMed ID: 20109351
[TBL] [Abstract][Full Text] [Related]
32. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis.
Leng T; Liu N; Dai Y; Yu Y; Zhang C; Du R; Chen X
J Proteome Res; 2010 Dec; 9(12):6207-19. PubMed ID: 20919743
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
[TBL] [Abstract][Full Text] [Related]
34. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
[TBL] [Abstract][Full Text] [Related]
35. Diethylnitrosamine enhances hepatic tumorigenic pathways in mice fed with high fat diet (Hfd).
Arboatti AS; Lambertucci F; Sedlmeier MG; Pisani G; Monti J; Álvarez ML; Francés DEA; Ronco MT; Carnovale CE
Chem Biol Interact; 2019 Apr; 303():70-78. PubMed ID: 30826251
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study.
Baokbah TAS
J Histotechnol; 2023 Mar; 46(1):5-16. PubMed ID: 36214360
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of antioxidant and stabilizing lipid peroxidation nature of Solanum xanthocarpum leaves in experimentally diethylnitrosamine induced hepatocellular carcinogenesis.
Velu P; Vijayalakshmi A; Iyappan P; Indumathi D
Biomed Pharmacother; 2016 Dec; 84():430-437. PubMed ID: 27682737
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
39. Effects of carnosine, taurine, and betaine pretreatments on diethylnitrosamine-induced oxidative stress and tissue injury in rat liver.
Başaran-Küçükgergin C; Bingül I; Tekkeşin MS; Olgaç V; Doğru-Abbasoğlu S; Uysal M
Toxicol Ind Health; 2016 Aug; 32(8):1405-1413. PubMed ID: 25552536
[TBL] [Abstract][Full Text] [Related]
40. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
